Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Cash & Equivalents (2010 - 2026)

Palatin Technologies' (PTN) quarterly Cash & Equivalents came in at $10.2 million in Q1 2026, up 303.14% YoY from $2.5 million in Q1 2025, and down 29.82% on a QoQ basis from $14.5 million in Q4 2025.

Palatin Technologies (PTN) Cash & Equivalents (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 17 years of Cash & Equivalents data on file, last reported at $10.2 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 303.14% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 million (up 303.14% YoY) and the FY2025 annual result came in at $2.6 million, down 73.09% from the prior year.
  • Cash & Equivalents eased to $10.2 million in Q1 2026, from $14.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $37.7 million in Q1 2022 to a low of $1.3 million in Q3 2025.
  • A 5-year average of $12.3 million and a median of $9.5 million in 2024 frame the typical range for Cash & Equivalents.
  • The widest YoY moves for Cash & Equivalents: up 323.7% in 2025, down 74.83% in 2025.
  • Tracing PTN's Cash & Equivalents over 5 years: stood at $21.2 million in 2022, then tumbled by 55.22% to $9.5 million in 2023, then sank by 63.98% to $3.4 million in 2024, then soared by 323.7% to $14.5 million in 2025, then dropped by 29.82% to $10.2 million in 2026.
  • The last three Cash & Equivalents figures came in at $10.2 million (Q1 2026), $14.5 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Palatin Technologies 40.37 Mn 40.37 Mn - 10.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.16 Mn
Dec 31, 2025 14.48 Mn
Sep 30, 2025 1.27 Mn
Jun 30, 2025 2.56 Mn
Mar 31, 2025 2.52 Mn
Dec 31, 2024 3.42 Mn
Sep 30, 2024 2.38 Mn
Jun 30, 2024 9.53 Mn
Mar 31, 2024 10.01 Mn
Dec 31, 2023 9.49 Mn
Sep 30, 2023 5.52 Mn
Jun 30, 2023 7.99 Mn
Mar 31, 2023 19.63 Mn
Dec 31, 2022 21.18 Mn
Sep 30, 2022 21.19 Mn
Jun 30, 2022 29.94 Mn
Mar 31, 2022 37.72 Mn
Dec 31, 2021 47.33 Mn
Sep 30, 2021 52.55 Mn
Jun 30, 2021 60.10 Mn